Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim University of Applied Sciences, Paul-Wittsack-Str. 10, 68163 Mannheim, Germany.
Sirius Fine Chemicals SiChem GmbH, Fahrenheitstr. 1, 28359 Bremen, Germany.
Anal Chem. 2020 May 5;92(9):6224-6228. doi: 10.1021/acs.analchem.9b05630. Epub 2020 Apr 20.
Several diseases are associated with disturbed redox signaling and altered metabolism of sulfur-containing metabolites and proteins. Importantly, oxidative degradation of fresh-frozen tissues begins within the normal time scale of MALDI MSI sample preparation. As a result, analytical methods that preserve the redox state of the tissue are urgently needed for refined studies of the underlying mechanisms. Nevertheless, no derivatization strategy for free sulfhydryl groups in tissue is known for MALDI MSI. Here, we report the first derivatization reagent, ()-2-cyano--(2-(2,5-dioxo-2,5-dihydro-1-pyrrol-1-yl)ethyl)-3-(4-hydroxyphenyl)acrylamide (CHC-Mal), for selective detection of free thiols using MALDI MSI. We performed in situ derivatization of free thiol groups from thiol-containing metabolites such as glutathione and cysteine and reduced proteins such as insulin and imaged their spatial distribution in porcine and mouse xenograft tissue. Derivatization of thiol-containing metabolites with CHC-Mal for MALDI MSI was also possible when using aged tissue in the presence of excess reducing agents. Importantly, CHC-Mal-derivatized low mass-metabolites could be detected without the use of a conventional MALDI matrix.
几种疾病与氧化还原信号的紊乱以及含硫代谢物和蛋白质代谢的改变有关。重要的是,新鲜冷冻组织的氧化降解在 MALDI MSI 样品制备的正常时间范围内开始。因此,迫切需要保存组织氧化还原状态的分析方法,以对潜在机制进行精细化研究。然而,对于 MALDI MSI 来说,还没有针对组织中游离巯基的衍生化策略。在这里,我们报告了第一个衍生化试剂()-2-氰基--(2-(2,5-二氧代-2,5-二氢-1-吡咯-1-基)乙基)-3-(4-羟基苯基)丙烯酰胺 (CHC-Mal),用于使用 MALDI MSI 选择性检测游离硫醇。我们对含硫醇的代谢物(如谷胱甘肽和半胱氨酸)和还原蛋白(如胰岛素)中的游离巯基进行了原位衍生化,并在猪和鼠异种移植组织中对其空间分布进行了成像。当存在过量还原剂时,即使使用陈旧的组织,CHC-Mal 也可以对含硫醇的代谢物进行衍生化,用于 MALDI MSI。重要的是,无需使用传统的 MALDI 基质即可检测到 CHC-Mal 衍生化的低质量代谢物。